Physician profile
Larry Bartolo Guinto
NPI 1497109144
$9,365.31
in general payments reported to CMS, 2019-2025
18 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 94% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $653 · 2022: $2,009 · 2023: $2,996 · 2024: $2,128 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,793 · Education: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,793.28 |
| Education | $910.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,409.20 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Infinion 16 |
| Painteq LLC | $1,731.85 | 2023-2024 | Painteq |
| Abbott Laboratories | $1,315.82 | 2022-2025 | Proclaim |
| Medtronic, INC. | $1,173.19 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $909.41 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $598.02 | 2024-2025 | Evoke |
| Vertos Medical, INC. | $355.19 | 2022-2024 | Mild Device Kit |
| Globus Medical, INC. | $185.57 | 2025 | Senza |
| Nalu Medical, INC. | $163.59 | 2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $141.14 | 2023-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $139.88 | 2025 | |
| Hydrocision, INC. | $67.61 | 2024 | Tenjet |
| Si-Bone, INC. | $46.16 | 2021 | |
| Relievant Medsystems, INC. | $44.64 | 2023 | Intracept |
| Orthofix Medical, INC. | $37.31 | 2023-2025 | Spinal-Stim, Spinal-Stim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.41 | 2024 | Evenity, Prolia |
| Biotronik Nro, INC. | $22.32 | 2025 | Prospera |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$75,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Guinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.